Aromatase Inhibitor [EPC]

113925 reported adverse events

Drugs of this class: ANASTROZOLE LETROZOLE EXEMESTANE ANASTROZOLE TABLETS LETROZOLE TABLETS

These side effects are most commonly reported by patients taking drugs of the Aromatase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 12163
1 NAUSEA 9108
2 DIARRHOEA 7925
3 ARTHRALGIA 7861
4 ALOPECIA 6764
5 MALIGNANT NEOPLASM PROGRESSION 6548
6 NEUTROPENIA 6537
7 PAIN 5580
8 DYSPNOEA 5219
9 WHITE BLOOD CELL COUNT DECREASED 5146
See all common reactions for Aromatase Inhibitor [EPC]

Drugs of the Aromatase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARBOHYDRATE ANTIGEN 15-3 INCREASED 409 0.5375
1 BREAST CANCER METASTATIC 2855 0.2656
2 BREAST CANCER RECURRENT 837 0.2647
3 METASTASES TO BONE 3594 0.2188
4 TUMOUR MARKER INCREASED 903 0.1880
5 METASTASES TO SPINE 599 0.1781
6 METASTASES TO LIVER 2530 0.1438
7 BONE LESION 509 0.1410
8 METASTASES TO LUNG 1510 0.1306
9 METASTASES TO LYMPH NODES 861 0.1274
See all enriched reactions for Aromatase Inhibitor [EPC]